Boston Scientific recently shared new clinical data sets on the use of its Eluvia drug-eluting stent for treating peripheral ...

Despite the evident success stories, the adoption of AI/ML in chemical engineering faces unique challenges. Unlike consumer applications where vast data sets are readily available, chemical processes ...

Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have developed a technique that could help advance ...

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and ...

In this interview, Sir Prof. Cato T. Laurencin, the 2025 Coulter Lecturer, discusses how he is addressing today’s medical ...

A senior lecturer at Wheelock College of Education and Development, Raul Fernandez teaches classes about improving diversity ...

Woock comes from Axonics, a neuromodulation company acquired by Boston Scientific for $3.7 billion in November ... He holds a Ph.D. in Biomedical Engineering from Duke University. "Joining Precision ...

genetic engineering, genomics, exercise and kinesiology, sports physiology, nutrition, pharmacology, epidemiology, and more. With its grounding in the sciences and mathematics, along with a complement ...

The Francis College of Engineering has been recognized as exemplar and with a Bronze Award for the inaugural ASEE Diversity Recognition Program. The ASEE Diversity Recognition Program (ADRP) was ...

“The extent of the federal investment in research, including biomedical research ... Harvard’s teaching hospitals in Boston were among the nation’s largest recipients of NIH grants last ...

Boston Scientific has a 12-month low of $70.97 and a 12-month high of $107.17. The business’s 50 day moving average is $98.68 and its 200-day moving average is $94.92.